Andrea Veysey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea Veysey has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ben Gelbart
Paediatric Intensive Care Unit, Murdoch Children’s Research Institute, University of Melbourne, Parkville, VIC, Australia
2 shared publications - Kate Masterson
Paediatric Intensive Care Unit, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia
2 shared publications - Andrew Goodwin
University of Sydney
1 shared publication - Bradley G. Carter
Paediatric and Neonatal Intensive Care Units, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia
1 shared publication - Emma Macdonald‐Laurs
Clinical Sciences Murdoch Children's Research Institute Melbourne Victoria Australia
1 shared publication Gabby Hall
Paediatric and Neonatal Intensive Care Units, Royal Children’s Hospital, Parkville, VIC, Australia
1 shared publication
Latest Publications
- 21 October 2026
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
Hemodynamic Patterns Relative to Vasopressin Initiation and Subsequent Septic Shock Progression in Children: A Retrospective Cohort, 2020–2023
Objectives: To describe the hemodynamic patterns associated with starting vasopressin in children with septic shock and to compare the early patterns based on subsequent progression of shock. Design: Retrospective cohort (2020–2023) study. Setting: Single-center, tertiary PICU in Australia. Patients: Children younger than 18 years with septic shock. Interventions: None. Measurements and Main Results: Hemodynamic variables collected at 1-minute intervals during a 1-hour observation period after starting vasopressin infusion were reviewed and collated according to whether shock subsequently progressed in the following 5 hours. In a cohort of 30 children (median age, 9 yr [interquartile range, 2–14 yr]), eight had shock progression, which was defined by echocardiography, lactate, and use of extracorporeal support. Cases with subsequent shock progression, as opposedto not, had an associated higher Phoenix score (7 [7–8] vs. 6 [5–6]; p = 0.01). The vasopressin starting dose in the shock vs. nonshock progression groups was 0.03 U/kg/hr (0.02–0.06 U/kg/hr) vs. 0.02 U/kg/hr (0.02–0.04 U/kg/hr; p = 0.72). We failed to find an association between ventricular dysfunction at baseline and the shock progression group vs. no shock progression (4/6 vs. 7/18; mean difference, 28%; 95% CI, –16% to 71%; p = 0.36). In the shock progression group, earlier pulse pressure continued on a decreasing trajectory following vasopressin initiation, despite increasing systolic and diastolic blood pressures. In those without shock progression, pulse pressure increased marginally. The difference between groups in the median pulse pressures during the observation period was 7.5 mm Hg. Conclusions: In this hypothesis-generating, retrospective study of children with septic shock treated with vasopressin, subsequent shock progression was associated with early decreasing pulse pressure. Further studies are needed to test whether early changes in pulse pressure after starting vasopressin can be used as a potential marker of subsequent shock progression.
- 21 October 2026
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
Hemodynamic Patterns Relative to Vasopressin Initiation and Subsequent Septic Shock Progression in Children: A Retrospective Cohort, 2020–2023
Objectives: To describe the hemodynamic patterns associated with starting vasopressin in children with septic shock and to compare the early patterns based on subsequent progression of shock. Design: Retrospective cohort (2020–2023) study. Setting: Single-center, tertiary PICU in Australia. Patients: Children younger than 18 years with septic shock. Interventions: None. Measurements and Main Results: Hemodynamic variables collected at 1-minute intervals during a 1-hour observation period after starting vasopressin infusion were reviewed and collated according to whether shock subsequently progressed in the following 5 hours. In a cohort of 30 children (median age, 9 yr [interquartile range, 2–14 yr]), eight had shock progression, which was defined by echocardiography, lactate, and use of extracorporeal support. Cases with subsequent shock progression, as opposedto not, had an associated higher Phoenix score (7 [7–8] vs. 6 [5–6]; p = 0.01). The vasopressin starting dose in the shock vs. nonshock progression groups was 0.03 U/kg/hr (0.02–0.06 U/kg/hr) vs. 0.02 U/kg/hr (0.02–0.04 U/kg/hr; p = 0.72). We failed to find an association between ventricular dysfunction at baseline and the shock progression group vs. no shock progression (4/6 vs. 7/18; mean difference, 28%; 95% CI, –16% to 71%; p = 0.36). In the shock progression group, earlier pulse pressure continued on a decreasing trajectory following vasopressin initiation, despite increasing systolic and diastolic blood pressures. In those without shock progression, pulse pressure increased marginally. The difference between groups in the median pulse pressures during the observation period was 7.5 mm Hg. Conclusions: In this hypothesis-generating, retrospective study of children with septic shock treated with vasopressin, subsequent shock progression was associated with early decreasing pulse pressure. Further studies are needed to test whether early changes in pulse pressure after starting vasopressin can be used as a potential marker of subsequent shock progression.
- Open Access
- 11 September 2026
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (10) , 1881-1893
The Sound Environment in the PICU : A Scoping Review Describing Sound Levels, Interventions and Patient Impacts
Elevated sound levels are associated with increased morbidity in adult and neonatal intensive care; however, their impact in the paediatric intensive care unit (PICU) remains poorly characterised. The aim of this scoping review was to characterise sound exposure in the PICU, including its measurement, sources, and associations with patient outcomes. MEDLINE, Embase, PsycINFO (Ovid), and PubMed were searched up to 5 November 2025 for full‐text, peer‐reviewed publications within the past 10 years to reflect the contemporary PICU environment. Titles, abstracts, and full texts were independently screened by two authors, and results were reported according to the PRISMA Extension for Scoping Reviews. Thirty‐six publications were included. Publications were grouped into five domains: measurement of sound levels; sources of sound; patient impacts; sound reduction interventions including care bundles incorporating sound descriptions; and other. Reported sound levels varied substantially across studies, reflecting heterogeneity in measurement approaches and clinical contexts. Most studies reported sound levels above WHO recommendations, and several reported maximum levels exceeding 80 dBA. Sound sources were broadly categorised as medical equipment, human activity, and environmental factors. Links between elevated sound and clinically meaningful outcomes remain uncertain. Intervention studies were limited, often behaviour‐focused, and rarely evaluated patient‐centred outcomes or clinical sustainability. Current evidence suggests WHO recommended sound levels are rarely achieved. The sound environment in the PICU is multifaceted, reflecting the interaction of clinical equipment, human activity, and environmental systems. There is a need for interventional research to evaluate whether modification of the PICU sound environment meaningfully improves patient outcomes.
- 11 September 2026
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (10) , 1881-1893
Open AccessThe Sound Environment in the PICU : A Scoping Review Describing Sound Levels, Interventions and Patient Impacts
Elevated sound levels are associated with increased morbidity in adult and neonatal intensive care; however, their impact in the paediatric intensive care unit (PICU) remains poorly characterised. The aim of this scoping review was to characterise sound exposure in the PICU, including its measurement, sources, and associations with patient outcomes. MEDLINE, Embase, PsycINFO (Ovid), and PubMed were searched up to 5 November 2025 for full‐text, peer‐reviewed publications within the past 10 years to reflect the contemporary PICU environment. Titles, abstracts, and full texts were independently screened by two authors, and results were reported according to the PRISMA Extension for Scoping Reviews. Thirty‐six publications were included. Publications were grouped into five domains: measurement of sound levels; sources of sound; patient impacts; sound reduction interventions including care bundles incorporating sound descriptions; and other. Reported sound levels varied substantially across studies, reflecting heterogeneity in measurement approaches and clinical contexts. Most studies reported sound levels above WHO recommendations, and several reported maximum levels exceeding 80 dBA. Sound sources were broadly categorised as medical equipment, human activity, and environmental factors. Links between elevated sound and clinically meaningful outcomes remain uncertain. Intervention studies were limited, often behaviour‐focused, and rarely evaluated patient‐centred outcomes or clinical sustainability. Current evidence suggests WHO recommended sound levels are rarely achieved. The sound environment in the PICU is multifaceted, reflecting the interaction of clinical equipment, human activity, and environmental systems. There is a need for interventional research to evaluate whether modification of the PICU sound environment meaningfully improves patient outcomes.